Hepatitis C virus coinfection and superinfection

被引:50
作者
Blackard, Jason T. [1 ]
Sherman, Kenneth E. [1 ]
机构
[1] Univ Cincinnati, Coll Med, Div Digest Dis, Cincinnati, OH 45267 USA
关键词
D O I
10.1086/510858
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A hallmark of RNA viruses is their extreme genetic diversity. Within an individual, the hepatitis C virus (HCV) exists as a population of distinct but closely related viral variants, termed the "viral quasispecies." These variants may display divergent replicative capacity, cell tropism, immunologic escape, and antiviral-drug resistance. Coinfection with 2 or more distinct HCVs has been frequently documented. Moreover, several cases of HCV superinfection have been reported recently. However, few data are available regarding the clinical consequences of coinfection and superinfection, although these phenomena have important implications for HCV vaccine design and development, as well as for the efficacy of HCV therapeutic agents.
引用
收藏
页码:519 / 524
页数:6
相关论文
共 67 条
[1]   Hepatitis C flare due to superinfection by genotype 4 in an HCV genotype 1b chronic carrier [J].
Accapezzato, D ;
Fravolini, F ;
Casciaro, MA ;
Paroli, M .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2002, 14 (08) :879-881
[2]   Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity [J].
Adinolfi, LE ;
Gambardella, M ;
Andreana, A ;
Tripodi, MF ;
Utili, R ;
Ruggiero, G .
HEPATOLOGY, 2001, 33 (06) :1358-1364
[3]  
[Anonymous], 2002, NIH CONSENS STATE SC, V19, P1
[4]   Second infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapy [J].
Asselah, T ;
Vidaud, D ;
Doloy, A ;
Boyer, N ;
Martinot, M ;
Vidaud, M ;
Valla, D ;
Marcellin, P .
GUT, 2003, 52 (06) :900-902
[5]   Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users [J].
Backmund, M ;
Meyer, K ;
Edlin, BR .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (10) :1540-1543
[6]   Treatment of hepatitis C infection in injection drug users [J].
Backmund, M ;
Meyer, K ;
Von Zielonka, M ;
Eichenlaub, D .
HEPATOLOGY, 2001, 34 (01) :188-193
[7]   Epidemiological changes in hepatitis C virus genotypes in France:: evidence in intravenous drug users [J].
Bourlière, M ;
Barberin, JM ;
Rotily, M ;
Guagliardo, V ;
Portal, I ;
Lecomte, L ;
Benali, S ;
Boustière, C ;
Perrier, H ;
Jullien, M ;
Lambot, G ;
Loyer, R ;
LeBars, O ;
Daniel, R ;
Khiri, H ;
Halfon, P .
JOURNAL OF VIRAL HEPATITIS, 2002, 9 (01) :62-70
[8]   Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users [J].
Bowden, S ;
McCaw, R ;
White, PA ;
Crofts, N ;
Aitken, CK .
JOURNAL OF VIRAL HEPATITIS, 2005, 12 (03) :322-324
[9]  
CAI Z, 2005, NAT MED, V11, P791
[10]   Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells [J].
Cai, ZH ;
Zhang, C ;
Chang, KS ;
Jiang, JY ;
Ahn, BC ;
Wakita, T ;
Liang, TJ ;
Luo, GX .
JOURNAL OF VIROLOGY, 2005, 79 (22) :13963-13973